Terns Pharmaceuticals reports topline 12-week data from its phase 2 trial evaluating oral GLP-1 receptor agonist TERN-601 in obesity
Side effects may include nausea, vomiting, diarrhea, constipation, and abdominal pain
When they present with that extra stress, we don't go and explain that they have oxidative stress
Supporting our understanding, there has been no case report dating back to 1965 documenting any allergic reaction of any related sulfate- or sulfite-related drug to patients with a history of a sulfa allergy
IV glutathione promises faster results, but heres the kicker it comes with serious risks including anaphylaxis and liver toxicity
Its also used to inhibit the production of inflammatory cytokines that lead to infection or respiratory conditions